Part 1: Assessing Pain and Initiating Non-Opioid Pain Management
Webcast
1.5 AMA PRA Category 1 Credits™ ...Faculty
OVERVIEW
Part 1: Assessing Pain and Initiating Non-Opioid Pain Management is organized by Pri-Med.
Release Date: 11/22/2024
Expiration Date: 10/31/2025
Description:
Assessing Pain and Initiating Non-Opioid Pain Management is Part 1 of the 3-part curriculum, P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025, which examines the full spectrum of pain management options available to clinicians, including the safe and effective use of opioids.
In Part 1, you will learn how to recognize, diagnose, and classify pain and how to perform an accurate pain assessment, including assessment of risk factors for abuse; you will also learn about the myriad nonpharmacologic and nonopioid treatment options for pain.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
Each activity will cover various state-specific content and guidelines, also available for download.
Learners must complete three parts; Part 1: Assessing Pain and Initiating Non-Opioid Pain Management, Part 2: Reducing Risks with Opioid Use, and Part 3: Approaches to Opioid Treatment and Counseling Patients, in order to be a fully FDA Blueprint compliant completer
Learning Objectives
- Discuss the definitions and mechanisms of pain
- Identify risk factors and stratification for opioid-related aberrant behavior and opioid use disorder as part of the initial assessment
- Apply individualized recommendations for nonpharmacologic and non-opioid treatment options for patients in pain
Topics
- Cultural Competency & Humility - Implicit Bias
- Controlled Substances
- Controlled Substances - Alabama
- Controlled Substances - Louisiana (NP)
- Controlled Substances - Michigan
- Controlled Substances - New Mexico
- Controlled Substances - New York
- Controlled Substances - Tennessee
- Controlled Substances - Vermont
- Controlled Substances - Drug Diversion, WV Board Approved
- Controlled Substances - Prescribing
- Controlled Substances - Prescribing, WV Board Approved
- Medical Ethics & Legal Issues
- Medical Ethics & Legal Issues - Patient Safety
- Medical Ethics & Legal Issues - Professional Responsibility
- Medical Ethics & Legal Issues - Risk Management
- Controlled Substances - Drug Diversion
- Controlled Substances - PDMP
- Controlled Substances - Schedule II/III
- MATE Act
- Psychiatry & Behavioral Health - Addiction
- Psychiatry & Behavioral Health - Substance Abuse
- Psychiatry & Behavioral Health - Substance Use Disorder
- Opioids
- Opioids - Abuse
- Opioids - Addiction
- Opioids - Opioid Antagonists
- Opioids - Prescribing
- Pain Management
- Non-pharmacologic Pain Management & Implantable Devices
ACCREDITATION & CREDITS
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute and Miller Medical Communications.Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of Pri-Med Institute and Miller Medical Communications. Pri-Med Institute is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider Number 040308.
Designation Statement
This activity is approved for 1.52 contact hour, which includes 0.25 hour of pharmacology.
MOC Credit Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points and Patient Safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Pri-Med Institute reports completion information to ACCME on a monthly basis, in the first week of each month. Pri-Med Institute reports completion information to ACCME on a monthly basis, in the first week of each month.
TARGET AUDIENCE
PhysicianPain ManagementPsychiatristsBehavioral Health NursesNurse PractitionersSPECIALITIES
Pain ManagementPsychiatryBehavioral Health
Quick Links